Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Toes

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Nature Medicine|June 3, 2000
A dual function for CD40 agonistsE Zanelli, R E Toes
The Journal of Experimental Medicine|March 2, 1999
CD4 T cells and their role in antitumor immune responsesR E Toes, F Ossendorp, R Offringa, et al.
Current Opinion in Immunology|October 1, 1996
Peptide-based cancer vaccinesC J Melief, R Offringa, R E Toes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumorsR E Toes, R J Blom, R Offringa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance inductionR E Toes, R Offringa, R J Blom, et al.
Immunology Letters|September 21, 2000
Importance of CD4(+) T helper cell responses in tumor immunityF Ossendorp, R E Toes, R Offringa, et al.
Current Opinion in Immunology|September 28, 2000
Design and evaluation of antigen-specific vaccination strategies against cancerR Offringa, S H van der Burg, F Ossendorp, et al.
Seminars in Immunology|November 25, 1998
CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunityR E Toes, S P Schoenberger, E I van der Voort, et al.
Arthritis and Rheumatism|March 3, 2007
Association of tumor necrosis factor alpha polymorphism and radiographic progression in rheumatoid arthritis: comment on the article by Khanna et alA H van der Helm-van Mil, F A Kurreeman, R E Toes, et al.
Nature|June 12, 1998
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactionsS P Schoenberger, R E Toes, E I van der Voort, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Nature Medicine|June 3, 2000
A dual function for CD40 agonistsE Zanelli, R E Toes
The Journal of Experimental Medicine|March 2, 1999
CD4 T cells and their role in antitumor immune responsesR E Toes, F Ossendorp, R Offringa, et al.
Current Opinion in Immunology|October 1, 1996
Peptide-based cancer vaccinesC J Melief, R Offringa, R E Toes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumorsR E Toes, R J Blom, R Offringa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance inductionR E Toes, R Offringa, R J Blom, et al.
Immunology Letters|September 21, 2000
Importance of CD4(+) T helper cell responses in tumor immunityF Ossendorp, R E Toes, R Offringa, et al.
Current Opinion in Immunology|September 28, 2000
Design and evaluation of antigen-specific vaccination strategies against cancerR Offringa, S H van der Burg, F Ossendorp, et al.
Seminars in Immunology|November 25, 1998
CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunityR E Toes, S P Schoenberger, E I van der Voort, et al.
Arthritis and Rheumatism|March 3, 2007
Association of tumor necrosis factor alpha polymorphism and radiographic progression in rheumatoid arthritis: comment on the article by Khanna et alA H van der Helm-van Mil, F A Kurreeman, R E Toes, et al.
Nature|June 12, 1998
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactionsS P Schoenberger, R E Toes, E I van der Voort, et al.
Pageof 6